참고문헌 (32)

1. Song, Kyoung-Ho, Kim, Eu Suk, Sin, Hye-yun, Park, Kyung-Hwa, Jung, Sook-In, Yoon, Nara, Kim, Dong-Min, Lee, Chang Seop, Jang, Hee-Chang, Park, Yoonseon, Lee, Kkot Sil, Kwak, Yee Gyung, Lee, Jae Hoon, Park, Seong Yeon, Song, Minkyo, Park, Sue K, Lee, Yeong-Seon, Kim, Hong Bin. Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort study. BMC infectious diseases, vol.13, 581-581.

   상세보기

2. Kim, E. S., Song, J. S., Lee, H. J., Choe, P. G., Park, K. H., Cho, J. H., Park, W. B., Kim, S. H., Bang, J. H., Kim, D. M.. A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea. The Journal of antimicrobial chemotherapy, vol.60, no.5, 1108-1114.

   상세보기

3. Soriano, Alex, Marco, Francesc, Martínez, José A, Pisos, Elena, Almela, Manel, Dimova, Veselka P, Alamo, Dolores, Ortega, Mar, Lopez, Josefina, Mensa, Josep. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.46, no.2, 193-200.

   상세보기

4. Jacob, J.T., DiazGranados, C.A.. High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, vol.17, no.2, e93-e100.

   상세보기

5. Mavros, M.N., Tansarli, G.S., Vardakas, K.Z., Rafailidis, P.I., Karageorgopoulos, D.E., Falagas, M.E.. Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta-regression. International journal of antimicrobial agents, vol.40, no.6, 496-509.

   상세보기

6. van Hal, S. J., Lodise, T. P., Paterson, D. L.. The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.54, no.6, 755-771.

   상세보기

7. Holmes, Natasha E., Turnidge, John D., Munckhof, Wendy J., Robinson, James O., Korman, Tony M., O’Sullivan, Matthew V. N., Anderson, Tara L., Roberts, Sally A., Gao, Wei, Christiansen, Keryn J., Coombs, Geoffrey W., Johnson, Paul D. R., Howden, Benjamin P.. Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations. The Journal of infectious diseases : official publication of the Infectious Diseases Society of America, vol.204, no.3, 340-347.

   상세보기

8. 10.3201/eid/1706.101037 

   

9. Rojas, L., Bunsow, E., Munoz, P., Cercenado, E., Rodriguez-Creixems, M., Bouza, E.. Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients. The Journal of antimicrobial chemotherapy, vol.67, no.7, 1760-1768.

   상세보기

10. Jung, Y., Song, K.H., Cho, J.e., Kim, H.s., Kim, N.H., Kim, T.S., Choe, P.G., Chung, J.Y., Park, W.B., Bang, J.H., Kim, E.S., Park, K.U., Park, S.W., Kim, H.B., Kim, N.J., Oh, M.d.. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia. International journal of antimicrobial agents, vol.43, no.2, 179-183.

    상세보기

11. Albur, M. S., Bowker, K., Weir, I., MacGowan, A.. Factors influencing the clinical outcome of methicillin-resistant Staphylococcus aureus bacteraemia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol.31, no.3, 295-301.

    상세보기

12. Song, K.H., Kim, H.B., Kim, H.s., Lee, M.J., Jung, Y., Kim, G., Hwang, J.H., Kim, N.H., Kim, M., Kim, C.J., Choe, P.G., Chung, J.Y., Park, W.B., Kim, E.S., Park, K.U., Kim, N.J., Kim, E.C., Oh, M.d.. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia. International journal of antimicrobial agents, vol.46, no.6, 689-695.

    상세보기

13. Kalil, Andre C, Van Schooneveld, Trevor C, Fey, Paul D, Rupp, Mark E. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.. JAMA : the journal of the American Medical Association, vol.312, no.15, 1552-1564.

    상세보기

14. Walraven, Carla J, North, Michael S, Marr-Lyon, Lisa, Deming, Paulina, Sakoulas, George, Mercier, Ren?e-Claude. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.. The Journal of antimicrobial chemotherapy, vol.66, no.10, 2386-2392.

    상세보기

15. van Hal, Sebastian J., Jensen, Slade O., Vaska, Vikram L., Espedido, Björn A., Paterson, David L., Gosbell, Iain B.. Predictors of Mortality in Staphylococcus aureus Bacteremia. Clinical microbiology reviews, vol.25, no.2, 362-386.

    상세보기

16. Howden, Benjamin P., Johnson, Paul D. R., Ward, Peter B., Stinear, Timothy P., Davies, John K.. Isolates with Low-Level Vancomycin Resistance Associated with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrobial agents and chemotherapy, vol.50, no.9, 3039-3047.

    상세보기

17. Bae, In-Gyu, Federspiel, Jerome J, Miró, José M, Woods, Christopher W, Park, Lawrence, Rybak, Michael J, Rude, Thomas H, Bradley, Suzanne, Bukovski, Suzana, de la Maria, Cristina Garcia, Kanj, Souha S, Korman, Tony M, Marco, Francesc, Murdoch, David R, Plesiat, Patrick, Rodriguez-Creixems, Marta, Reinbott, Porl, Steed, Lisa, Tattevin, Pierre, Tripodi, Marie-Françoise, Newton, Karly L, Corey, G Ralph, Fowler, Vance G. Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.. The Journal of infectious diseases : official publication of the Infectious Diseases Society of America, vol.200, no.9, 1355-1366.

    상세보기

18. van Hal, Sebastiaan J., Paterson, David L.. Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates. Antimicrobial agents and chemotherapy, vol.55, no.1, 405-410.

    상세보기

19. Cervera, Carlos, Castañeda, Ximena, de la Maria, Cristina Garcia, del Rio, Ana, Moreno, Asunción, Soy, Dolors, Pericas, Juan Manuel, Falces, Carlos, Armero, Yolanda, Almela, Manel, Ninot, Salvador, Pare, Juan Carlos, Mestres, Carlos A., Gatell, Jose M., Marco, Francesc, Miro, Jose M., Miró, José M., Moreno, Asuncion, del Río, Ana, Cervera, Carlos, Pericas, Juan M., Castañeda, Ximena, Gatell, Jose M., Marco, Francesc, Almela, Manel, Jiménez-de-Anta, Maria T., de la Mària, Cristina Garcia, Armero, Yolanda, Mestres, Carlos A., Paré, Juan C., Falces, Carlos, Cartañá, Ramón, Ninot, Salvador, Azqueta, Manel, Sitges, Marta, Heras, Magda, Pomar, José L., Ramírez, Jose, Ribalta, Teresa, Brunet, Merce, Soy, Dolors, Llopis, Jaume. Effect of Vancomycin Minimal Inhibitory Concentration on the Outcome of Methicillin-Susceptible Staphylococcus aureus Endocarditis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.58, no.12, 1668-1675.

    상세보기

20. López-Cortóés, L. E., Velasco, C., Retamar, P., del Toro, M. D., Góéálvez-Acebal, J., de Cueto, M., Garcóéáía-Luque, I., Caballero, F. J., Pascual, A., Rodróéáííguez-Baóéáííño, J.. Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?. The Journal of antimicrobial chemotherapy, vol.70, no.9, 2652-2660.

    상세보기

21. Kaasch, Achim J., Jung, Norma, Fätkenheuer, Gerd, Seifert, Harald. Vancomycin Minimum Inhibitory Concentration in Methicillin-Susceptible Staphylococcus aureus and Mortality: More Than Handwaving?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.60, no.4, 668-668.

    상세보기

22. Keel, R.A., Sutherland, C.A., Aslanzadeh, J., Nicolau, D.P., Kuti, J.L.. Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies. Diagnostic microbiology and infectious disease, vol.68, no.3, 326-329.

    상세보기

23. van Hal, S. J., Barbagiannakos, T., Jones, M., Wehrhahn, M. C., Mercer, J., Chen, D., Paterson, D. L., Gosbell, I. B.. Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns. The Journal of antimicrobial chemotherapy, vol.66, no.10, 2284-2287.

    상세보기

24. Prybylski, John P. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients withStaphylococcus aureusBacteremia: A Meta-analysis of Observational Studies. Pharmacotherapy, vol.35, no.10, 889-898.

    상세보기

25. Holmes, Natasha E., Turnidge, John D., Munckhof, Wendy J., Robinson, J. Owen, Korman, Tony M., O'Sullivan, Matthew V. N., Anderson, Tara L., Roberts, Sally A., Warren, Sanchia J. C., Coombs, Geoffrey W., Tan, Hui-Leen, Gao, Wei, Johnson, Paul D. R., Howden, Benjamin P.. Genetic and Molecular Predictors of High Vancomycin MIC in Staphylococcus aureus Bacteremia Isolates. Journal of clinical microbiology, vol.52, no.9, 3384-3393.

    상세보기

26. 10.1093/cid/cir858 

    

27. Ludwig, Franziska, Edwards, Becky, Lawes, Timothy, Gould, Ian M.. Effects of Storage on Vancomycin and Daptomycin MIC in Susceptible Blood Isolates of Methicillin-Resistant Staphylococcus aureus. Journal of clinical microbiology, vol.50, no.10, 3383-3387.

    상세보기

28. Falcíón, Rocío, Madrid, Silvia, Tormo, Nuria, Casaíóñ, Cristina, Albert, Eliseo, Gimeno, Concepciíóñón, Navarro, David. Intra- and Interinstitutional Evaluation of an Etest for Vancomycin Minimum Inhibitory Concentration Measurement in Staphylococcus aureus Blood Isolates. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.61, no.9, 1490-1492.

    상세보기

29. Klevens, R. M., Morrison, M. A., Nadle, J., Petit, S., Gershman, K., Ray, S., Harrison, L. H., Lynfield, R., Dumyati, G., Townes, J. M.. Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States. JAMA : the journal of the American Medical Association, vol.298, no.15, 1763-1771.

    상세보기

30. Harbarth, S, Rutschmann, O, Sudre, P, Pittet, D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus.. Archives of internal medicine, vol.158, no.2, 182-189.

    상세보기

31. Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R.. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of chronic diseases, vol.40, no.5, 373-383.

    상세보기

32. Document M07-A9 Clinical and Laboratory Standards Institute 2009 9 Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard, 9th ed. Document M07-A9. CLSI, Wayne, PA.